Bayview Pharmacy is pleased to present a distinctive compounded formulation of Acyclovir 5%/Imiquimod 2.5%/Tea Tree Oil 2.5%/Deoxy-D-Glucose. This formulation is specifically designed to address a range of skin conditions such as herpes, warts, and fungal infections. The formulation is encapsulated in solid dosage forms composed of two gelatin or vegetarian shells. This design allows for easy swallowing and ensures a precise dosage of the active ingredients.

Acyclovir, a key component of this formulation, is an antiviral medication that works to mitigate the severity and duration of herpes outbreaks. Imiquimod, another active ingredient, is an immune response modifier that aids in reducing the size and number of warts. Tea Tree Oil, a natural antifungal agent, is included to inhibit the growth of fungal infections. Lastly, Deoxy-D-Glucose, a sugar molecule, is incorporated to decrease inflammation and promote healing.

This unique formulation provides an effective treatment for various skin conditions. It can be used safely and effectively with minimal side effects. However, patients should be aware that this formulation may cause skin irritation and should be used with caution. For any questions or concerns regarding this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive care and guidance for our patients.

This compounded formulation of Acyclovir 5%/Imiquimod 2.5%/Tea Tree Oil 2.5%/Deoxy-D-Glucose is designed to provide targeted treatment for various disease states, including herpes simplex virus (HSV) infections, genital warts, and molluscum contagiosum. The formulation is encased in two gelatin or vegetarian shells, which allows for easy swallowing and ensures a precise dosage of the active ingredients.

Acyclovir, an antiviral medication, works by inhibiting the replication of HSV. Imiquimod, an immune response modifier, stimulates the body's own immune system to fight the virus. Tea Tree Oil, an essential oil with antiseptic and anti-inflammatory properties, can help reduce inflammation and itching associated with HSV infections. Deoxy-D-Glucose, a sugar molecule, aids in reducing the replication of HSV.

It is important to note that this formulation is not recommended for use in pregnant or breastfeeding women, as the safety of the ingredients in this formulation has not been established in these populations. Patients should also be aware that this formulation may cause skin irritation, redness, and itching. If any of these side effects occur, patients should discontinue use and contact their healthcare provider.

This formulation should not be used in combination with other topical medications, as this may increase the risk of skin irritation. Patients should also avoid contact with the eyes, as this may cause irritation. For any questions or concerns regarding this formulation or its use, please reach out to your healthcare provider.

This compounded formulation combines Acyclovir 5%, Imiquimod 2.5%, Tea Tree Oil 2.5%, and Deoxy-D-Glucose, each contributing its unique therapeutic properties to create a comprehensive treatment option. Acyclovir, an antiviral medication, is effective against infections caused by certain types of viruses, including herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. It functions by inhibiting the replication of the virus, thereby limiting its spread.

Imiquimod, an immune response modifier, is used in the treatment of actinic keratosis, a precancerous skin condition, as well as genital and perianal warts. It works by stimulating the body’s immune system to fight the virus, enhancing the body's natural defense mechanisms.

Tea Tree Oil, an essential oil, is known for its antifungal, antibacterial, and antiviral properties. It contributes to the formulation by directly attacking and killing the virus, providing an additional layer of defense.

Deoxy-D-Glucose, a sugar molecule, has demonstrated anti-inflammatory and antioxidant properties. It aids in reducing inflammation and oxidative stress, which can contribute to the overall health of the skin and enhance the healing process.

This formulation is designed to treat a variety of disease states, including herpes simplex virus infections, varicella-zoster virus infections, Epstein-Barr virus infections, actinic keratosis, and genital and perianal warts. It is available in a topical cream or ointment form and should be applied to the affected area as directed by your healthcare provider. It is crucial to follow the instructions provided by your healthcare provider and to use the medication as directed. If you have any questions about this formulation or how to use it, please consult with your healthcare provider.

This compounded formulation of Acyclovir 5%/Imiquimod 2.5%/Tea Tree Oil 2.5%/Deoxy-D-Glucose is encased in two gelatin or vegetarian shells, creating a solid dosage form that is easy to swallow and provides a precise dosage of the active ingredients. This formulation has been effectively used in the treatment of various skin conditions including Herpes Simplex, Genital Warts, Molluscum Contagiosum, Actinic Keratosis, and Basal Cell Carcinoma. It may also be beneficial for other skin conditions such as acne, psoriasis, and eczema.

Acyclovir, an antiviral medication, is a key component of this formulation. It works by reducing the severity and duration of herpes outbreaks. Imiquimod, an immune response modifier, is another active ingredient that helps to activate the body’s natural defenses against viral infections. The formulation also contains Tea Tree Oil, an essential oil known for its antiseptic and anti-inflammatory properties, which can help to reduce redness and swelling. Deoxy-D-Glucose, a sugar molecule, is included in the formulation for its ability to reduce inflammation and promote healing.

This formulation is intended for topical use to treat a variety of skin conditions. It is crucial to follow the instructions of your healthcare provider when using this formulation. If you have any questions or concerns, please consult with your healthcare provider for further guidance.